[Necrotizing pneumonia due to Staphylococcus aureus producing Panton-Valentine toxin]

N Brulé1, S Jaffré, S Chollet

  • 1Service de Soins intensifs de pneumologie, Hôpital Laennec, CHU de Nantes, France. noellebrule@hotmail.com

Abstract

Insights

Necrotizing pneumonia caused by Staphylococcus aureus producing Panton Valentine Leukocidine (PVL) can be fatal. Early diagnosis and specific antibiotic treatment are crucial for favorable outcomes in affected young adults.

Area of Science:

  • Pulmonary Medicine
  • Infectious Diseases
  • Microbiology

Background:

  • Necrotizing pneumonia caused by Staphylococcus aureus strains producing Panton Valentine Leukocidine (PVL) is a severe condition with high mortality.
  • PVL is a toxin implicated in severe staphylococcal infections, particularly in otherwise healthy individuals.

Observation:

  • A case of severe necrotizing pneumonia with extensive lung lesions in a young adult is presented.
  • The patient experienced acute respiratory and haemodynamic failure, ARDS, and multiple pneumothoraces.
  • Diagnosis was challenging due to atypical bronchoscopic findings and initial lack of response to broad-spectrum antibiotics, with PVL identified in blood and tracheal aspirates.

Findings:

  • Despite severe complications, the patient achieved a favorable outcome.
  • Successful treatment involved antibiotics (flucloxacillin, clindamycin) and corticosteroids.

Implications:

  • Highlights the importance of considering PVL-producing Staphylococcus aureus in necrotizing pneumonia, especially in young adults with poor response to standard treatment.
  • Emphasizes the complexity of managing such cases due to extensive tissue damage and the need for targeted antimicrobial therapy effective against both the bacteria and its toxin.

Related Concept Videos

Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following: